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Résumé en
anglais
Cardiovascular magnetic resonance imaging (CMR) has become a key investigative
tool in patients with suspected myocarditis. However, the prognostic implications of
T1 mapping, including extracellular volume (ECV) calculation, is less clear. Patients
with suspected myocarditis who underwent CMR evaluation, including T1 mapping at
our institution were included. CMR findings including late gadolinium enhancement
(LGE), left ventricular ejection fraction (LVEF), native T1 mapping, and ECV
calculation were associated with first major adverse cardiac events (MACE). MACE
included a composite of all-cause death, heart failure hospitalization, heart
transplantation, documented sustained ventricular arrhythmia, and recurrent
myocarditis. One hundred seventy-nine patients with a mean age of 49 ± 15 years
were identified. Seventy nine individuals (44%) were female. Mean LVEF was 48 ± 16.
At a median follow-up of 4.1 [interquartile-range (IQR) 2.2-6.1] years, 22 (12%)
patients experienced a MACE. Mean ECV (per 10%) was significantly associated with
MACE (HR 2.09, 95% CI 1.07-4.08, p = 0.031). Presence of ECV ≥ 35% demonstrated
significant univariable association with MACE (HR 3.3, 95% CI 1.43-7.97, p = 0.005)
and such association was maintained when adjusted to LVEF (HR 3.42, 95% CI
1.42-7.94, p = 0.006). ECV ≥ 35% portended a greater than threefold increased
hazards to MACE adjusted to LGE presence (HR 3.14, 95% CI 1.29-7.36, p = 0.012). In
patients without LGE, ECV ≥ 35% portended a greater than sixfold increased hazards
(HR 6.6, p = 0.010). In the multivariable model including age, LVEF and LGE size,
only ECV ≥ 35% maintained its significant association with outcome. ECV calculation
by CMR is a useful tool in the risk stratification of patients with clinically suspected
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